Neurogene Inc. (NGNE)
USD 16.97
(10.19%)
USD 16.97
(10.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -131.95 Million USD | -70.63% |
| 2022 | -77.33 Million USD | -18.36% |
| 2021 | -65.33 Million USD | 63.79% |
| 2020 | -180.43 Million USD | -27.17% |
| 2019 | -141.88 Million USD | -84.45% |
| 2018 | -76.92 Million USD | -47.93% |
| 2017 | -51.99 Million USD | -61.22% |
| 2016 | -32.25 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -97.24 Million USD | 28.35% |
| 2024 Q1 | -135.73 Million USD | -1.87% |
| 2023 FY | -131.95 Million USD | -70.63% |
| 2023 Q2 | -54.65 Million USD | -129.53% |
| 2023 Q3 | -14.53 Million USD | 73.41% |
| 2023 Q1 | -23.81 Million USD | 7.77% |
| 2023 Q4 | -133.24 Million USD | -816.82% |
| 2022 Q4 | -25.81 Million USD | 8.66% |
| 2022 FY | -77.33 Million USD | -18.36% |
| 2022 Q3 | -28.26 Million USD | 56.58% |
| 2022 Q2 | -65.09 Million USD | 43.56% |
| 2022 Q1 | -115.34 Million USD | 10.92% |
| 2021 Q2 | -151.56 Million USD | 0.0% |
| 2021 Q4 | -129.48 Million USD | 9.14% |
| 2021 FY | -65.33 Million USD | 63.79% |
| 2021 Q3 | -142.5 Million USD | 5.98% |
| 2020 FY | -180.43 Million USD | -27.17% |
| 2019 FY | -141.88 Million USD | -84.45% |
| 2018 FY | -76.92 Million USD | -47.93% |
| 2017 FY | -51.99 Million USD | -61.22% |
| 2016 FY | -32.25 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | -81.761% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 180.28% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.057% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -175059.954% |
| Apollomics, Inc. | -27.39 Million USD | -381.675% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -20023.374% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -49.169% |
| Bicycle Therapeutics plc | -481.46 Million USD | 72.593% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -2.2% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 464.89% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3275.048% |
| Chimerix, Inc. | -25.51 Million USD | -417.126% |
| CRISPR Therapeutics AG | -150.84 Million USD | 12.523% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 174.271% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 52.155% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1821.526% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1821.526% |
| Gritstone bio, Inc. | 39.49 Million USD | 434.148% |
| Allakos Inc. | -24.97 Million USD | -428.348% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -513.43% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1363.565% |
| Cytokinetics, Incorporated | 642.37 Million USD | 120.542% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -83.927% |
| Innoviva, Inc. | 255.56 Million USD | 151.633% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1328.519% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18027.061% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -225.237% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2252.027% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -66.351% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -245.957% |
| ImmuCell Corporation | 10.99 Million USD | 1300.621% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 14.396% |
| Incyte Corporation | -3.17 Billion USD | 95.844% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 929.99% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11006.061% |
| Mustang Bio, Inc. | -3.73 Million USD | -3431.986% |
| MiMedx Group, Inc. | -33.9 Million USD | -289.236% |
| MEI Pharma, Inc. | -3.7 Million USD | -3461.538% |
| MacroGenics, Inc. | -66.98 Million USD | -96.992% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1716.041% |
| Mereo BioPharma Group plc | -51.46 Million USD | -156.378% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -773.212% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1191.903% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 466.491% |
| Minerva Neurosciences, Inc. | 41 Million USD | 421.808% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -493.536% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5099.173% |
| NextCure, Inc. | -6.47 Million USD | -1937.286% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -357.034% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -161.292% |
| Onconetix, Inc. | 5.33 Million USD | 2575.036% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1968.584% |
| Opthea Limited | 28.15 Million USD | 568.633% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 795.958% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2013.89% |
| PDS Biotechnology Corporation | -32.7 Million USD | -303.422% |
| Precigen, Inc. | -481 Thousand USD | -27333.472% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -658.536% |
| Prime Medicine, Inc. | -27.94 Million USD | -372.263% |
| PureTech Health plc | -167.19 Million USD | 21.078% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -327.565% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -386.919% |
| Replimune Group, Inc. | 1.41 Million USD | 9445.255% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1000.386% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 574.778% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5595.013% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 78.304% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -612.506% |
| Sesen Bio, Inc. | -112.55 Million USD | -17.238% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1758.521% |
| Solid Biosciences Inc. | -47.75 Million USD | -176.346% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 55.081% |
| SciSparc Ltd. | -2.06 Million USD | -6290.073% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 216.279% |
| TG Therapeutics, Inc. | 17.86 Million USD | 838.747% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -771.853% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2025.564% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 138.07% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3105.124% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -448.966% |
| XOMA Corporation | -29 Million USD | -355.017% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 844.037% |
| AbCellera Biologics Inc. | -55.94 Million USD | -135.887% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -852.331% |
| Cassava Sciences, Inc. | -121.13 Million USD | -8.931% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1993.708% |
| Precision BioSciences, Inc. | -85.41 Million USD | -54.496% |
| Dyadic International, Inc. | -6.37 Million USD | -1968.877% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1471.267% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -728.187% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -333.207% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -296.774% |
| IGM Biosciences, Inc. | -72.6 Million USD | -81.741% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -220.396% |
| Acelyrin, Inc. | -216.9 Million USD | 39.164% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1354.37% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -685.961% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1444.566% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 58.346% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -70.372% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7683.621% |
| Mesoblast Limited | 55.96 Million USD | 335.79% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -421.726% |
| ChromaDex Corporation | -24.04 Million USD | -448.715% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15206.424% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 315.412% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1674.033% |
| Seer, Inc. | -4.24 Million USD | -3012.146% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 181.584% |
| Novavax, Inc. | -298.29 Million USD | 55.763% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1343.47% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 313.983% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2577.658% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -59.984% |
| Celcuity Inc. | 6.78 Million USD | 2045.232% |
| ContextLogic Inc. | -232 Million USD | 43.123% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 45.555% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -19.376% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.875% |
| Amarin Corporation plc | -191.04 Million USD | 30.928% |
| AnaptysBio, Inc. | -18.15 Million USD | -626.985% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1046.737% |
| Aptorum Group Limited | 1.35 Million USD | 9823.694% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -100.065% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3183.061% |
| Ardelyx, Inc. | 34.51 Million USD | 482.345% |
| Celularity Inc. | 65.19 Million USD | 302.416% |
| Omeros Corporation | 331.17 Million USD | 139.844% |
| Humacyte, Inc. | -22.48 Million USD | -486.832% |
| Immunocore Holdings plc | -358.59 Million USD | 63.202% |
| IO Biotech, Inc. | -140.69 Million USD | 6.215% |
| GT Biopharma, Inc. | -1.02 Million USD | -12824.094% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 29.893% |
| Summit Therapeutics Inc. | 34.67 Million USD | 480.559% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2076.757% |
| Pulmatrix, Inc. | -10.41 Million USD | -1166.727% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -18.449% |
| Evogene Ltd. | -19.63 Million USD | -572.074% |
| CorMedix Inc. | -43.05 Million USD | -206.498% |
| BioLineRx Ltd. | 7.33 Million USD | 1898.732% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -12.738% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -75.767% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 26.272% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1916.119% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -795.096% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 2.544% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18027.061% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -612.506% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 36.61% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -42.25% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -492.045% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 28.521% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -394.974% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1184.865% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -690.521% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2458.303% |
| bluebird bio, Inc. | 108.57 Million USD | 221.538% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 134.84% |
| DBV Technologies S.A. | -126.98 Million USD | -3.913% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 24.696% |
| Galecto, Inc. | -21.21 Million USD | -521.96% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1839.659% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -43.852% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -94.673% |
| GlycoMimetics, Inc. | -40.98 Million USD | -221.964% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 213.176% |
| ADMA Biologics, Inc. | 90.06 Million USD | 246.509% |
| Clene Inc. | 3.34 Million USD | 4050.749% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 61.655% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1510.217% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4117.138% |
| Soligenix, Inc. | -4.95 Million USD | -2564.898% |
| Century Therapeutics, Inc. | 847 Thousand USD | 15679.103% |
| Kura Oncology, Inc. | -20.11 Million USD | -555.905% |
| Surrozen, Inc. | -32.66 Million USD | -303.977% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -222.423% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7343.529% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4027.463% |
| Autolus Therapeutics plc | -186.59 Million USD | 29.284% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -167.635% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 485.068% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -457.313% |
| GRI Bio, Inc. | -1.79 Million USD | -7255.351% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1368.934% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2572.456% |
| INmune Bio, Inc. | -25.41 Million USD | -419.283% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 187.416% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -160.477% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -712.062% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1320.211% |
| Jaguar Health, Inc. | 29.39 Million USD | 548.964% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4473.947% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 447.113% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1037.114% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 513.847% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 134.913% |
| Verastem, Inc. | -37.27 Million USD | -253.976% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -154.435% |
| Histogen Inc. | -7.48 Million USD | -1662.455% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -510.71% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -0.383% |
| Surrozen, Inc. | -32.66 Million USD | -303.977% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8656.138% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3039.179% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1474.426% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -203.75% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -805.236% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -18174.797% |
| Kronos Bio, Inc. | -36.05 Million USD | -265.993% |
| Turnstone Biologics Corp. | -14.58 Million USD | -804.793% |
| Synaptogenix, Inc. | -28.66 Million USD | -360.391% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -13997.756% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 21111.943% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 370.777% |
| Exelixis, Inc. | -73.05 Million USD | -80.637% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -449.515% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 45.331% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -56.901% |
| ESSA Pharma Inc. | -33.62 Million USD | -292.471% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4913.221% |
| Avid Bioservices, Inc. | 169.72 Million USD | 177.745% |
| Insmed Incorporated | 721.62 Million USD | 118.286% |
| MediWound Ltd. | -5.32 Million USD | -2379.425% |
| OmniAb, Inc. | 9.2 Million USD | 1533.826% |
| Alector, Inc. | -35.63 Million USD | -270.275% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 253.488% |
| Zai Lab Limited | -775 Million USD | 82.974% |
| AlloVir, Inc. | -62.69 Million USD | -110.481% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 138.747% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -901.86% |
| Aura Biosciences, Inc. | -21.52 Million USD | -513.031% |
| Immunic, Inc. | -45.34 Million USD | -191.034% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 31.706% |
| Veracyte, Inc. | -203.82 Million USD | 35.26% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 120.673% |
| FibroGen, Inc. | 56.76 Million USD | 332.45% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1581.808% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 1.584% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4567.534% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6273.566% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3849.566% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 20.492% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.408% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -439.208% |
| XBiotech Inc. | -200.02 Million USD | 34.03% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -56.901% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 58.335% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7554.002% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3014.201% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -274.202% |
| Agenus Inc. | 274.13 Million USD | 148.135% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -70.886% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2418.661% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 22.568% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -42.849% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 117.922% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1125.488% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -137.269% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3721.822% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1370.078% |
| Lantern Pharma Inc. | -21.7 Million USD | -507.996% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3020.241% |
| Ainos, Inc. | 4.07 Million USD | 3335.834% |
| Pluri Inc. | 22.82 Million USD | 678.015% |
| Prothena Corporation plc | -608.34 Million USD | 78.309% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -11.114% |
| Rallybio Corporation | -24.1 Million USD | -447.486% |
| Kodiak Sciences Inc. | -103.87 Million USD | -27.032% |
| Cue Biopharma, Inc. | -33.81 Million USD | -290.18% |
| MeiraGTx Holdings plc | -40.3 Million USD | -227.416% |
| Annexon, Inc. | -193.75 Million USD | 31.896% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -654.072% |
| Moderna, Inc. | -2.9 Billion USD | 95.461% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -436.948% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -327.025% |
| Blueprint Medicines Corporation | 702.83 Million USD | 118.775% |
| Immix Biopharma, Inc. | -17.5 Million USD | -653.607% |
| CalciMedica, Inc. | -5.53 Million USD | -2286.166% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -60.799% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -229.583% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 21.564% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -296.821% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2107.713% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -120.13% |
| Nutriband Inc. | -251.65 Thousand USD | -52334.464% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -286.749% |
| Vor Biopharma Inc. | 4.3 Million USD | 3168.721% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.814% |
| Alkermes plc | -166.73 Million USD | 20.861% |
| ProKidney Corp. | -56.23 Million USD | -134.645% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -171.111% |
| Arcellx, Inc. | -296.95 Million USD | 55.564% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.675% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -380.448% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 385.945% |
| Atai Life Sciences N.V. | -28.55 Million USD | -362.06% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6015.861% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -478.344% |
| MediciNova, Inc. | -50.78 Million USD | -159.838% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -67.445% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -586497.022% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1944.993% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 33.963% |
| Biomea Fusion, Inc. | -166.57 Million USD | 20.781% |
| RenovoRx, Inc. | -1.17 Million USD | -11149.361% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -39.128% |
| Geron Corporation | 14.76 Million USD | 993.943% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2989.947% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 43.714% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -40.063% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -37.89% |
| Royalty Pharma plc | 5.65 Billion USD | 102.332% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -237.714% |
| Imunon, Inc. | -4.21 Million USD | -3031.458% |
| BioAtla, Inc. | -109.01 Million USD | -21.047% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1202.749% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -522.341% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 6.236% |
| Structure Therapeutics Inc. | -124.33 Million USD | -6.125% |
| 89bio, Inc. | -289.05 Million USD | 54.349% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -696.83% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1671.446% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -5.872% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -61.356% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -15258.177% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3331.86% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8230.865% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.556% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 257.843% |
| Liquidia Corporation | -80.17 Million USD | -64.582% |
| Entera Bio Ltd. | -10.62 Million USD | -1141.462% |
| GH Research PLC | -78.07 Million USD | -69.006% |
| Vericel Corporation | 1.27 Million USD | 10433.203% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -651.281% |
| Xencor, Inc. | 29.64 Million USD | 545.132% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6598.863% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -712.062% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -53779.416% |
| Vaxcyte, Inc. | -368.22 Million USD | 64.165% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 4.2% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -4.381% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11006.061% |
| Portage Biotech Inc. | -4.98 Million USD | -2549.167% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -586497.022% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -99.563% |
| OncoCyte Corporation | -6.56 Million USD | -1910.59% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 14803.932% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2796.518% |
| Purple Biotech Ltd. | -14.13 Million USD | -833.336% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -610.62% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2151.792% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -124.333% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -455.46% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -474.317% |
| United Therapeutics Corporation | -507.7 Million USD | 74.009% |
| HilleVax, Inc. | -165.48 Million USD | 20.262% |
| Silo Pharma, Inc. | -3.52 Million USD | -3644.139% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 132360.522% |
| Pharming Group N.V. | 109.8 Million USD | 220.173% |
| Tharimmune, Inc. | -10.93 Million USD | -1106.683% |
| Genprex, Inc. | -6.73 Million USD | -1858.478% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -13.478% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 64.221% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1394.311% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9318.63% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3878.208% |
| OKYO Pharma Limited | -826.84 Thousand USD | -15858.798% |
| Savara Inc. | 153 Thousand USD | 86345.098% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1154.712% |
| Curis, Inc. | -23.88 Million USD | -452.413% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -16904.247% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11235.443% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.143% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 28.898% |
| Erasca, Inc. | -37.21 Million USD | -254.565% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10145.805% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10145.805% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1174.681% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1114.161% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -320.627% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -308.884% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -283.858% |
| Adicet Bio, Inc. | -138.78 Million USD | 4.923% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 166.622% |
| Aditxt, Inc. | 18.12 Million USD | 828.193% |
| Adagene Inc. | -87.62 Million USD | -50.586% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3067.862% |
| Quantum-Si incorporated | -118.55 Million USD | -11.301% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1665.476% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -172.022% |
| Compugen Ltd. | -12.9 Million USD | -922.59% |
| Generation Bio Co. | 31.44 Million USD | 519.597% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 24.754% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -326.721% |
| Invivyd, Inc. | -198.47 Million USD | 33.516% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -46.178% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5403.426% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -86.403% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1833.407% |
| 2seventy bio, Inc. | 181.71 Million USD | 172.616% |
| Instil Bio, Inc. | 75.35 Million USD | 275.104% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1352.816% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4134.264% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1944.993% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -407.525% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3125.048% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2433.212% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -1.267% |
| Evaxion Biotech A/S | 5.28 Million USD | 2595.912% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -17.222% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -0.52% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -156.174% |
| Cingulate Inc. | 3.08 Million USD | 4380.524% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4392.85% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1936.023% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -25.026% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3246.872% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1502.434% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9149.623% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -143.208% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 863.717% |
| ImmunityBio, Inc. | 618.22 Million USD | 121.344% |
| Korro Bio, Inc. | -132.94 Million USD | 0.743% |
| Kineta, Inc. | -4.54 Million USD | -2805.858% |
| BioVie Inc. | -17.73 Million USD | -644.148% |
| Codexis, Inc. | -43.27 Million USD | -204.95% |
| Celularity Inc. | 65.19 Million USD | 302.416% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 278.029% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4063.932% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3821.462% |
| Cibus, Inc. | -8.07 Million USD | -1533.511% |
| IN8bio, Inc. | -16.38 Million USD | -705.144% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 366641.667% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3656.191% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 112.516% |
| Eyenovia, Inc. | 1.25 Million USD | 10583.419% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 590.448% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3968.918% |
| Elevation Oncology, Inc. | -19.11 Million USD | -590.213% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -296.893% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -576.484% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -124.127% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -536.633% |
| Moolec Science SA | 117.61 Thousand USD | 112291.369% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -243.642% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -248.001% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 6.693% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -486.597% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1787.924% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2360.535% |
| Humacyte, Inc. | -22.48 Million USD | -486.832% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -422.76% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7300.729% |
| Genelux Corporation | -6.89 Million USD | -1812.669% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -324.853% |
| Notable Labs, Ltd. | -9.77 Million USD | -1249.785% |
| Immunovant, Inc. | -635.22 Million USD | 79.227% |
| Quantum-Si incorporated | -118.55 Million USD | -11.301% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3085.011% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1743.889% |
| Acasti Pharma Inc. | -23 Million USD | -473.593% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3818.801% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 22.048% |
| PepGen Inc. | -60.67 Million USD | -117.496% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -589.925% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15206.424% |
| Immuneering Corporation | -54.94 Million USD | -140.168% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3039.179% |
| Belite Bio, Inc | -87.27 Million USD | -51.201% |
| XOMA Corporation | -29 Million USD | -355.017% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -86.649% |
| Bionomics Limited | 227 Million USD | 158.127% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5109.435% |
| uniQure N.V. | -102.95 Million USD | -28.173% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3067.862% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 422.227% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1003.21% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4164.592% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 124585.849% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3968.918% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1581.808% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1679.328% |
| Altimmune, Inc. | -134.48 Million USD | 1.883% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 28.865% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5109.435% |
| Peak Bio, Inc. | 10.34 Million USD | 1376.141% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -46527.208% |
| Benitec Biopharma Inc. | -50.58 Million USD | -160.873% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -26.469% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 771.698% |
| Zura Bio Limited | -99.8 Million USD | -32.211% |
| PolyPid Ltd. | 6.17 Million USD | 2238.655% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 771.698% |
| argenx SE | -2.02 Billion USD | 93.496% |
| Immunome, Inc. | -97.02 Million USD | -35.995% |
| Verona Pharma plc | -220.44 Million USD | 40.141% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -83.927% |
| Shattuck Labs, Inc. | -121.42 Million USD | -8.673% |
| CervoMed Inc. | -7.79 Million USD | -1593.284% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2917.494% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -0.163% |
| Moolec Science SA | 117.61 Thousand USD | 112291.369% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5667.322% |
| Design Therapeutics, Inc. | -18.15 Million USD | -627.025% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -87.487% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1274.813% |
| Achilles Therapeutics plc | -126.92 Million USD | -3.964% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9149.623% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1673.589% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 138.788% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 655.951% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 70.511% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 5.955% |
| Beam Therapeutics Inc. | -262.72 Million USD | 49.774% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 704.854% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2603.996% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -136.208% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -32.14% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5520.385% |
| NeurAxis, Inc. | 145.7 Thousand USD | 90666.232% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -238.121% |
| Lumos Pharma, Inc. | -28.49 Million USD | -363.114% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -535.198% |
| Palisade Bio, Inc. | -12.06 Million USD | -993.882% |
| Nutriband Inc. | -251.65 Thousand USD | -52334.464% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -58.444% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2588.022% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 65.016% |
| Athira Pharma, Inc. | -88.99 Million USD | -48.266% |
| HCW Biologics Inc. | 2.85 Million USD | 4719.18% |
| XOMA Corporation | -29 Million USD | -355.017% |
| Nektar Therapeutics | 210.24 Million USD | 162.764% |
| Arvinas, Inc. | -313.8 Million USD | 57.949% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8230.865% |
| Merus N.V. | -192.88 Million USD | 31.588% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 319.98% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1801.917% |
| Rezolute, Inc. | -68.16 Million USD | -93.573% |
| Clene Inc. | 3.34 Million USD | 4050.749% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -900.645% |
| BeyondSpring Inc. | -13.75 Million USD | -859.324% |
| Synlogic, Inc. | -6.68 Million USD | -1873.897% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 11736.243% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1460.674% |
| Peak Bio, Inc. | 10.34 Million USD | 1376.141% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -60.101% |
| Krystal Biotech, Inc. | -350.23 Million USD | 62.324% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 206.308% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 21.918% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4079.569% |
| MannKind Corporation | 143.89 Million USD | 191.7% |
| Ikena Oncology, Inc. | -109.15 Million USD | -20.887% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1642.901% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -298.656% |
| Gossamer Bio, Inc. | 180.35 Million USD | 173.164% |
| CohBar, Inc. | -5.93 Million USD | -2124.937% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -343.576% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2989.947% |
| Legend Biotech Corporation | -949.39 Million USD | 86.101% |
| Mural Oncology plc | -255.84 Million USD | 48.423% |
| Disc Medicine, Inc. | -358.28 Million USD | 63.17% |
| Champions Oncology, Inc. | 4.81 Million USD | 2842.207% |
| REGENXBIO Inc. | 54.76 Million USD | 340.934% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -48970.868% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 12.626% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1364.213% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -63.547% |
| Vaxart, Inc. | -8.24 Million USD | -1501.201% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -162.963% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -3.766% |
| Cellectis S.A. | -43.85 Million USD | -200.889% |
| Longeveron Inc. | -2.9 Million USD | -4437.655% |
| Repare Therapeutics Inc. | -107.85 Million USD | -22.341% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.626% |
| Inozyme Pharma, Inc. | 12 Million USD | 1199.259% |
| Revolution Medicines, Inc. | -608.2 Million USD | 78.304% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10628.049% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 50.228% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 12.072% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -743.325% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -17731.757% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.62% |
| Denali Therapeutics Inc. | -74.86 Million USD | -76.257% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1000.386% |
| Veru Inc. | 4.77 Million USD | 2860.583% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1073.351% |
| Cingulate Inc. | 3.08 Million USD | 4380.524% |
| Passage Bio, Inc. | 4.58 Million USD | 2977.972% |
| Context Therapeutics Inc. | -14.44 Million USD | -813.194% |
| Exicure, Inc. | 5.84 Million USD | 2356.027% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 42.722% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -233.472% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 940.96% |
| Nuvalent, Inc. | -335.38 Million USD | 60.656% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7708.365% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -77.164% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1384.308% |
| OmniAb, Inc. | 9.2 Million USD | 1533.826% |
| Anew Medical, Inc. | 1.43 Million USD | 9311.743% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 905.5% |
| Lipocine Inc. | -4.75 Million USD | -2675.317% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -20.147% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 966.358% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -160.477% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 630.11% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1863.324% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -100.457% |
| Ocugen, Inc. | -32.52 Million USD | -305.753% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -54.198% |
| Q32 Bio Inc. | -37.94 Million USD | -247.726% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -20911.943% |
| Alumis Inc. Common Stock | -13.52 Million USD | -875.349% |
| Equillium, Inc. | -22.39 Million USD | -489.295% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -416.094% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -304.438% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -53125.904% |
| Dominari Holdings Inc. | 195 Thousand USD | 67769.231% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2405.359% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1379.814% |
| Bio-Techne Corporation | 267.74 Million USD | 149.283% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -714.085% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -11.737% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1470.332% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -943.04% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 46.167% |
| Nkarta, Inc. | 57.29 Million USD | 330.292% |
| BioCardia, Inc. | 212 Thousand USD | 62342.925% |
| Iterum Therapeutics plc | 13.43 Million USD | 1081.954% |